Strong First-Half Trading Supports Upgraded Outlook
Bunzl (LSE:BNZL) has improved its expectations for 2026 after reporting stronger-than-anticipated trading during the first half of the year.
The distribution and services group expects first-half revenue to increase by approximately 4% at constant exchange rates, with underlying revenue growth of around 3%. The company also anticipates a modest improvement in operating margins during the period.
Management attributed the performance to a combination of inflation in selected product categories, geopolitical-related cost increases and particularly strong volume growth within its North American Distribution division.
North American Business Continues to Deliver
Bunzl highlighted its North American operations as a key contributor to growth, benefiting from improved execution, enhanced service levels and stronger customer demand.
The business delivered solid volume gains during the period, helping offset more challenging conditions in other parts of the portfolio.
Management noted that operational improvements implemented across the region have continued to support performance and strengthen customer relationships.
Full-Year Revenue Expectations Increased
Following the stronger first-half performance, Bunzl now expects modest underlying revenue growth for the full 2026 financial year.
The company believes revenue will be supported by a combination of inflationary pricing effects and a small contribution from recent acquisitions.
Despite the improved sales outlook, Bunzl continues to expect full-year operating margins to be slightly lower than those achieved in the previous year, reflecting ongoing cost pressures and regional market challenges.
Scientifix Acquisition Strengthens Healthcare Platform
Alongside its trading update, Bunzl announced the acquisition of Scientifix Group in Australia.
Scientifix is a distributor serving the life sciences and biotechnology sectors and generates approximately AUD 18 million in annual revenue.
The acquisition expands Bunzl’s healthcare offering in Australia and strengthens its position in a market that management views as both attractive and highly fragmented.
The company sees further opportunities to pursue additional acquisitions in the sector as part of its long-term growth strategy.
Financial Strength Continues to Support Growth
Bunzl’s outlook remains supported by solid financial performance and strong cash generation.
The company continues to benefit from high-quality free cash flow, providing flexibility to pursue acquisitions and invest in organic growth initiatives.
While leverage levels and some recent pressure on profitability remain areas of focus, management believes the group’s financial position remains robust.
Outlook Remains Positive Despite Margin Pressure
The company’s outlook reflects a balance between encouraging revenue momentum and ongoing profitability challenges.
Technical indicators remain supportive, with positive share-price momentum underpinning investor sentiment.
Valuation metrics also appear reasonable relative to peers, supported by a mid-teen earnings multiple and a dividend yield of approximately 3.3%.
However, management remains cautious regarding operating margins, citing regional pressures and execution challenges that could continue to weigh on profitability during the remainder of the year.
More about Bunzl
Bunzl plc is an international distribution and services group that provides outsourced, value-added distribution solutions to businesses across a wide range of industries.
The company supplies essential products including healthcare, safety, cleaning, foodservice and distribution-related items to customers worldwide. Bunzl has a significant presence in North America, Europe, Australia and other international markets and continues to pursue growth through a combination of organic expansion and strategic acquisitions.
Leave a Reply